Alglucosidase alfa
Alglucosidase alfa (rhGAA) is a hydrolytic lysosomal glycogen-specific recombinant human α-glucosidase. Alglucosidase alfa can be used for Pompe disease research[1].
Product Specifications
CAS Number
420784-05-0
Product Name Alternative
RhGAA
UNSPSC
12352204
Target
Glycosidase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Solubility
10 mM in DMSO
Smiles
[Alglucosidasealfa]
References & Citations
[1]Dornelles AD, et al. Efficacy and safety of enzyme replacement therapy with alglucosidase alfa for the treatment of patients with infantile-onset Pompe disease: a systematic review and metanalysis. Front Pediatr. 2024 Feb 15;12:1310317.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog